Document is current

Article History

Received: 27 January 2025

Accepted: 23 February 2025

First Online: 30 May 2025

Declarations

:

: Prof. Geert D’Haens has served as advisor for AbbVie, Ablynx, Alimentiv, Amgen, AM Pharma, Biogen, Bristol Meiers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronic, Ferring, Dr Falk Pharma, Eli Lilly, Engene, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Immunic, Johnson and Johnson, Lamepro, Lument, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novo Nordisk, Otsuka, Pfizer, Polpharm, Prometheus Laboratories/Nestlé, Procise Diagnostics, Protagonist, Salix, Samsung Bioepis, Sandoz, Setpoint, Shire, Takeda, Tigenix, Tillotts, Topivert, Versant and Vifor and received speaker fees from AbbVie, Biogen, Ferring, Johnson and Johnson, Merck Sharp Dome, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Takeda, Tillotts, and Vifor. Prof. Willem Bemelman has received research funding from VIFOR, has a 4.9% share in Semiflex, received speakers fee from Galapagos, and is a consultant for Braun and Olympus. Dr. Christianne Buskens received an unrestricted grant from Boehringer Ingelheim and Roche. She has received consultancy/speakers fees from Tillotts, MSD, Takeda, Janssen, Galapagos. Dr. Marjolijn Duijvestein received Speaking fee from Bristol Meyers Squibb, Takeda, and Galapagos and served on an advisory board for Abbvie, Bristol Meyers Squibb, Celltrion, Galapagos, Janssen, Takeda. Received Grant/Research support from Pfizer, Bristol Meyers Squibb, Galapagos and Janssen. Dr. Oddeke van Ruler has served as an invited speaker for Janssen-Cilag and has received a research grant from Takeda and Janssen, outside the submitted work. Dr. Tim Stobernack has received research funding from ZonMw (file number 80-86800-98-112). Drs. Liesbeth Munster, MSc; Bas van der Zwet; Joline de Groof; Marco Mundt; and Jarmila van der Bilt have no conflicts of interest or financial ties to disclose.